journal article·1998-06

Synthetic biodegradable polymers for tissue engineering and drug delivery

Jeffrey A Hubbell

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Biomaterials in tissue engineering10.1038/nbt0695-565 ↗
2. Surface treatments of polymers for biocompatibility10.1146/annurev.ms.26.080196.002053 ↗
3. Tissue engineering10.1126/science.8493529 ↗
4. New challenges in biomaterials10.1126/science.8134835 ↗
5. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(α-hydroxy acid) diacrylate macromers10.1021/ma00056a005 ↗
6. Separation of the arterial-wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat - the roles of medial and luminal factors in arterial healing10.1073/pnas.93.23.13188 ↗
7. Characterization of partially saturated poly(propylene fumarate) for orthopedic application10.1163/156856297X00074 ↗
8. Synthesis and characterization of photo-cross-linked polymers based on poly (L-lactic acid-co-L-aspartic acid)10.1021/ma961411w ↗
9. Novel degradable poly(ethylene glycol) esters for drug-delivery
10. Improved local-delivery of TGFβ-2 by binding to injectable fibrillar collagen via difunctional polyethylene-glycol10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K ↗
11. Synthesis and characterization of enzymatically-cross-linked poly(ethylene glycol) hydrogels10.1021/ma970345a ↗
12. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo10.1038/359067a0 ↗
13. Biodegradable block-copolymers as injectable drug-delivery systems10.1038/42218 ↗
14. An RGD spacing of 440 nm is sufficient for integrin αvβ3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation10.1083/jcb.114.5.1089 ↗
15. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength10.1083/jcb.122.3.729 ↗
16. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable10.1002/(SICI)1097-4636(19970615)35:4<513::AID-JBM11>3.0.CO;2-C ↗
17. N-acetylglucosamine and adenosine derivatized surfaces for cell-culture — 3T3 fibroblast and chicken hepatocyte response10.1002/bit.260430815 ↗
18. Polymer substrates for controlled biological interactions10.1002/jcb.240560206 ↗
19. Vascular endothelial-cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin α4β110.1016/S0021-9258(19)49672-5 ↗
20. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B ↗
21. Crystal-structures of chain-folded antiparallel β-sheet assemblies from sequence-designed periodic polypeptides10.1021/ma9614050 ↗
22. Laminin oligopeptide derivatized agarose gels allow 3-dimensional neurite extension in-vitro10.1002/jnr.490410409 ↗
23. Fibroblast aggregation by suspension with conjugates of poly(ethylene glycol) and RGD10.1002/(SICI)1097-0290(19960520)50:4<349::AID-BIT1>3.3.CO;2-D ↗
24. Cell-binding peptides conjugated to poly(ethylene glycol) promote neural cell-aggregation10.1038/nbt0894-797 ↗
25. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase10.1038/nm0996-1022 ↗
26. Degradability of hydrogels containing azoaromatic cross-links10.1002/macp.1995.021960709 ↗
27. Enantioselective release of 5-fluorouracil from N-(2-hydroxypropyl)methacrylamide-based copolymers via lysosomal-enzymes10.1021/bc00034a019 ↗
28. Integration of surface modification and 3D fabrication techniques to prepare patterned poly(l-lactide) substrates allowing regionally selective cell-adhesion10.1163/156856298X00451 ↗
29. A nanotechnology for biomaterials engineering - structural characterization of amphiphilic polymeric nanoparticles by 1H-NMR spectroscopy10.1016/S0142-9612(96)00077-4 ↗
30. Design of functional polymeric micelles as site-specific drug vehicles based on poly(α-hydroxy ethylene oxide-co-benzyl L-aspartate) block-copolymers10.1016/S0928-4931(97)00007-6 ↗
31. Novel polyion complex micelles entrapping enzyme molecules in the core — preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block-copolymer in aqueous-medium.10.1021/ma971277v ↗
32. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol) poly(L-lysine) block-copolymer10.1021/js970304s ↗
33. Molecular manipulation of microstructures - biomaterials, ceramics, and semiconductors10.1126/science.277.5330.1242 ↗
34. Supramolecular materials — self-organized nanostructures10.1126/science.276.5311.384 ↗
35. Nanoapatite and organoapatite implants in bone — histology and ultrastructure of the interface10.1002/jbm.820290103 ↗
36. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas10.1016/S0140-6736(95)90755-6 ↗
37. Canine bone response to tyrosine-derived polycarbonates and poly(L-lactic acid)10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R ↗
38. Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterials10.1002/jbm.820280811 ↗
39. A combinatorial approach for polymer design10.1021/ja970389z ↗
40. Degradable and highly porous polyesterurethane foam as biomaterial — effects and phagocytosis of degradation products in osteoblasts10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7 ↗
41. Development of degradable polyesterurethanes for medical applications — in-vitro and in-vivo evaluations10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.0.CO;2-J ↗